In summary, by inhibiting HIF-1α, reducing angiogenesis, and increasing oxidative stress within cancer cells, both hyperbaric oxygen and ozone therapy can complement traditional cancer treatments and improve patient outcomes. The gene discussed is HIF1A; the disease is cancer.